Literature DB >> 19406641

Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding.

Christopher D Cox1, Georgia B McGaughey, Michael J Bogusky, David B Whitman, Richard G Ball, Christopher J Winrow, John J Renger, Paul J Coleman.   

Abstract

NMR spectroscopy, X-ray crystallography, and molecular modeling studies indicate that N,N-disubstituted-1,4-diazepane orexin receptor antagonists exist in an unexpected low-energy conformation that is characterized by an intramolecular pi-stacking interaction and a twist-boat ring conformation. Synthesis and evaluation of a macrocycle that enforces a similar conformation suggest that this geometry mimics the bioactive conformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406641     DOI: 10.1016/j.bmcl.2009.04.026

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

2.  The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts.

Authors:  Jason M Uslaner; William J Herring; Paul J Coleman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-28

3.  Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs.

Authors:  Georgia McGaughey; Christopher I Bayly; Christopher D Cox; John D Schreier; Michael J Breslin; Michael Bogusky; Steve Pitzenberger; Richard Ball; Paul J Coleman
Journal:  J Comput Aided Mol Des       Date:  2014-02-01       Impact factor: 3.686

4.  Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.

Authors:  Jie Yin; Juan Carlos Mobarec; Peter Kolb; Daniel M Rosenbaum
Journal:  Nature       Date:  2014-12-22       Impact factor: 49.962

5.  Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.

Authors:  Jie Yin; Kerim Babaoglu; Chad A Brautigam; Lindsay Clark; Zhenhua Shao; Thomas H Scheuermann; Charles M Harrell; Anthony L Gotter; Anthony J Roecker; Christopher J Winrow; John J Renger; Paul J Coleman; Daniel M Rosenbaum
Journal:  Nat Struct Mol Biol       Date:  2016-03-07       Impact factor: 15.369

6.  Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors.

Authors:  Changning Wang; Christian K Moseley; Stephen M Carlin; Colin M Wilson; Ramesh Neelamegam; Jacob M Hooker
Journal:  Bioorg Med Chem Lett       Date:  2013-04-02       Impact factor: 2.823

7.  A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging.

Authors:  Ping Bai; Sha Bai; Michael S Placzek; Xiaoxia Lu; Stephanie A Fiedler; Brenda Ntaganda; Hsiao-Ying Wey; Changning Wang
Journal:  Molecules       Date:  2020-02-25       Impact factor: 4.411

8.  The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship.

Authors:  Andrezza K Kim; Robyn M Brown; Andrew J Lawrence
Journal:  Front Behav Neurosci       Date:  2012-11-22       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.